ArmInfo.By the order of the RA Minister of Health Arsen Torosyan of August 11, the regulations on the implementation of the treatment of patients with COVID-19 with the drug Remdesivir in the repurposed medical institutions were approved.
According to the press service of the ministry, a form of "Informed consent" of the patient about the treatment with this drug, the form of the "Individual registration card of the patient", principles of treatment with the drug "Remdesivir" for patients with severe course of coronavirus were also established. To note, the drug Remdesivir was imported by the Indian pharmaceutical company Hetero Labs Limited, to which the pharmaceutical company Gilead Science issued a permit to manufacture the drug. The Ministry of Health of Armenia purchased 5020 ampoules of this drug, and received another 600 ampoules as humanitarian aid.
The drug "Remdesivir" is prescribed in a hospital setting as directed by a doctor to patients with severe or extremely severe COVID-19 disease. After reviewing the medication instructions and possible side effects of antiviral treatment, the patient or his legal representative signs a consent form for treatment. The main goal of drug treatment is to prevent further progression of the disease, reverse development of clinical symptoms, and improve laboratory and instrumental data. Treatment may be more effective if the virus is eliminated more quickly (negative PCR test result).
As a reminder, there is currently no approved World Health Organization guideline for the special antiviral treatment of COVID-19.
As of August 12, 40,794 cases of coronavirus were confirmed in Armenia, 33,492 people recovered, 806 died.